Ignite Creation Date:
2024-05-06 @ 2:05 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04211922
Status:
TERMINATED
Last Update Posted:
2024-04-26
First Post:
2019-12-23
Brief Title:
Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Sponsor:
Suzhou Zelgen Biopharmaceuticals CoLtd
Organization:
Suzhou Zelgen Biopharmaceuticals CoLtd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-23
First Submit QC Date:
December 23 2019
Study First Post Date:
2019-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-25
Last Update Post Date:
2024-04-26
Last Update Post Date Type:
ACTUAL